Zevia PBC (NYSE:ZVIA - Get Free Report)'s stock had its "sell (d-)" rating reissued by equities research analysts at Weiss Ratings in a report issued on Wednesday,Weiss Ratings reports.
Several other equities analysts have also weighed in on the stock. Telsey Advisory Group lifted their target price on shares of Zevia PBC from $5.00 to $6.00 and gave the company an "outperform" rating in a report on Thursday, August 14th. Morgan Stanley lifted their target price on shares of Zevia PBC from $2.50 to $2.70 and gave the company an "equal weight" rating in a report on Tuesday, August 12th. Finally, BMO Capital Markets lifted their target price on shares of Zevia PBC from $5.00 to $6.00 and gave the company an "outperform" rating in a report on Thursday, August 7th. Two equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Zevia PBC has an average rating of "Hold" and an average target price of $4.61.
Check Out Our Latest Stock Report on Zevia PBC
Zevia PBC Trading Down 0.2%
Shares of ZVIA traded down $0.01 during mid-day trading on Wednesday, reaching $2.30. The company had a trading volume of 265,381 shares, compared to its average volume of 719,333. The stock has a market cap of $172.01 million, a price-to-earnings ratio of -10.43 and a beta of 0.88. The firm has a fifty day simple moving average of $2.75 and a 200-day simple moving average of $2.72. Zevia PBC has a fifty-two week low of $0.96 and a fifty-two week high of $4.99.
Zevia PBC (NYSE:ZVIA - Get Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The company reported ($0.01) earnings per share for the quarter, beating analysts' consensus estimates of ($0.05) by $0.04. The company had revenue of $44.52 million for the quarter, compared to analyst estimates of $41.63 million. Zevia PBC had a negative net margin of 8.97% and a negative return on equity of 27.86%. As a group, equities analysts predict that Zevia PBC will post -0.32 EPS for the current fiscal year.
Hedge Funds Weigh In On Zevia PBC
A number of institutional investors have recently added to or reduced their stakes in ZVIA. Bank of America Corp DE lifted its holdings in Zevia PBC by 2,845.4% in the 4th quarter. Bank of America Corp DE now owns 15,817 shares of the company's stock worth $66,000 after buying an additional 15,280 shares in the last quarter. Emerald Mutual Fund Advisers Trust lifted its holdings in Zevia PBC by 28.2% in the 1st quarter. Emerald Mutual Fund Advisers Trust now owns 381,007 shares of the company's stock worth $823,000 after buying an additional 83,778 shares in the last quarter. Emerald Advisers LLC lifted its holdings in Zevia PBC by 67.2% in the 1st quarter. Emerald Advisers LLC now owns 90,871 shares of the company's stock worth $196,000 after buying an additional 36,512 shares in the last quarter. American Century Companies Inc. acquired a new position in Zevia PBC in the 1st quarter worth $67,000. Finally, Walleye Capital LLC acquired a new position in Zevia PBC in the 1st quarter worth $95,000. Institutional investors and hedge funds own 53.21% of the company's stock.
Zevia PBC Company Profile
(
Get Free Report)
Zevia PBC, a beverage company, develops, markets, sells, and distributes various carbonated beverages in the United States and Canada. It offers soda, energy drinks, organic tea, and kidz drinks. The company offers its products through a network of food, drug, warehouse club, mass, natural, convenience, and e-commerce channels, as well as grocery distributors and natural product stores and specialty outlets.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Zevia PBC, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zevia PBC wasn't on the list.
While Zevia PBC currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.